A Key for Succes: Removing Intellectual Property Bottlenecks for Commercialization of Life Science Research
The Steinbeis-Transfer-Institute for IP Management in collaboration with Steinbeis Team North East has developed a set of indicators for the assessment of commercially viable public-private collaborative projects in Life sciences. This will significantly improve the possibilities for successful trans-national knowledge transfer in ScanBalt BioRegion. The indicators targets four main dimensions namely technology, intellectual property, the market situation and the exploitation of technology transfer options. The development of the indicators is part of the EU FP 7 Co-funded project Bridge-BSR.
Frank Graage, Head of Steinbeis Team North East says “With the development of indicators we have taken a major step forward towards bridging Life science academic research and SMEs in ScanBalt BioRegion. We will now implement the indicators within e.g. environmental life sciences as this has priority in order to support the development of a strong eco-industrial sector. Overall, this promotes an effective Eco-agenda for the Baltic Sea Region and assist to establish the region as a global frontrunner within a sector, which is likely to boom the coming years”.
The summary of the report on indicators can be downloaded at: /files/graphics/ScanBalt/Activities/BridgeBSR/09-02-09_Executive_Summary_BridgeBSR_WP2_Indicators.pdf
For further information on the full report please contact Stephan Hundertmark at Tel +49 (0) 89 / 74 63 92 – 19 or e-mail email@example.com
For further information on Bridge-BSR please see bridge-bsr
For further information on ScanBalt BioRegion, please seewww.scanbalt.org. At the end of 2008 ScanBalt BioRegion had 2393 life science companies.
5 April 2019
The German Market for Health & Care Technologies